fda guidelines semaglutide The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Two-year effects of semaglutide in
Description
New research details improved liver health and reduced heart disease risk.
Free consultation serving all of Florida.
Congress has introduced the SAFE Drugs Act of 2025, a bill that would significantly expand federal oversight of compounding pharmacies and outsourcing facilities, with particular focus on GLP-1 drugs and telehealth distribution models
GLP-1 compounding faces legal challenges, evolving FDA rules, and heightened enforcement risks.
